Log In
CQMS
Make a Donation
Log In
Donate
DONATE OR FUNDRAISE
Donate
Read Angelo's story about taking part in our kidney cancer trial
Sign up now to join our Km's for Cancer Research Challenge in October
Submit your trial idea by 6 October for our 2026 Concept Development Workshop
Abstract submissions for TROG 2027 ASM close 9 October: Submit your abstract now.
TROG ASM Attendance Grants: Applications now open

TROG 96.07 – Merkel Cell – Skin

Completed
Skin

A Phase II Study of Synchronous Carboplatin/Etoposide And Radiation In Merkel Cell Carcinoma Of The Skin

Primary Sponsor

Trans-Tasman Radiation Oncology Group (TROG)
Prev Post

TROG 97.01 – Bladder (Phase II)

Next Post

TROG 96.06 – Melanoma (Phase II)

Related Post

26 September, 2026

Trial finds radiation therapy halves risk of brain tumour recurrence after surgery

LATEST NEWS: 26 September 2026 Giving radiotherapy after surgery

17 September, 2026

Meet the TROG Quality Assurance team

TROG UPDATES: 17 September 2026 Our Quality Assurance team